[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.41.181. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
January 1994

Assessment of Hepatitis B Virus Immunization Status Among North American Surgeons

Author Affiliations

From the Department of Surgery, Cornell University, New York, NY (Dr Barie); the Department of Surgery, University of Washington, Seattle (Dr Dellinger); the Department of Surgery, Texas Tech Univeristy, El Paso (Dr Dougherty); the Department of Surgery, Harvard University, Boston, Mass (Dr Fink); and the Scientific Studies Committee, Surgical Infection Society (Drs Barie, Dellinger, Dougherty, and Fink).

Arch Surg. 1994;129(1):27-32. doi:10.1001/archsurg.1994.01420250039004
Abstract

Objective:  We hypothesized that many surgeons have not been vaccinated against hepatitis B virus (HBV), despite the existence of effective recombinant vaccines. Prevalence of HBV vaccination among surgeons, attitudes of those not vaccinated, estimated HBV infection rates, and respondents' knowledge of the epidemiology of HBV exposure were determined.

Design:  Survey conducted by mail just before implementation of mandatory HBV vaccination for health care workers.

Setting:  Private and academic general surgical, trauma and transplantation practices.

Participants:  Two thousand one hundred twenty-five surgeons received the survey. Response rates are as follows: in the Surgical Infection Society, 196 (50%) of 393 surgeons; in the American Association for the Surgery of Trauma, 223 (52%) of 433 surgeons; in the American Society of Transplant Surgeons, 194 (44%) of 438 surgeons; and among the Fellows of the American College of Surgeons, 403 (47%) of 861 surgeons.

Main Outcome Measures:  Prevalence of HBV exposure and active immunization by specialty and society.

Results:  Prevalence of HBV exposure was 19.6%, was higher among trauma and transplantation surgeons compared with general surgeons (P<.0001), and increased significantly with age in all groups (P<.05). Despite greater exposure, probable immunity was lower at an older age because young surgeons (age, <46 years) are more likely to be vaccinees (P<.05). Most surgeons (55%) were vaccinated more than 5 years ago; many recipients of recombinant vaccines (26%) received an inadequate amount of vaccine or were improperly vaccinated. Knowledge of the epidemiology was uniformly poor, with rates of correct responses to the three questions below 50%.

Conclusions:  Vaccination does not equal immunity. Between 38% and 50% of practicing surgeons may not have adequate immunity to HBV.(Arch Surg. 1994;129:27-32)

References
1.
Centers for Disease Control Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public safety workers . MMWR Morb Mortal Wkly Rep . 1989;38:1-37.
2.
Popejoy SL, Fry DE.  Blood contact and exposure in the operating room . Surg Gynecol Obstet . 1991;172:480-483.
3.
Fry DE.  Hepatitis: a continued occupational risk for surgeons . Perspect Gen Surg . 1992;3:25-36.
4.
Centers for Disease Control.  Recommendations for protection against viral hepatitis . MMWR Morb Mortal Wkly Rep . 1985;34:313-314.
5.
Henderson DK, Fahey BJ, Willy M, et al.  Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures: a prospective evaluation . Ann Intern Med . 1990;113:740-746.Article
6.
Reingold AL, Kane MA, Hightower AW.  Failure of gloves and other protective devices to prevent transmission of hepatitis B virus to oral surgeons . JAMA . 1988;259:2558-2560.Article
7.
Buergler JM, Kim R, Thisted RA, Cohn SJ, Lichor JL, Roizen MF.  Risk of human immunodeficiency virus in surgeons, anesthesiologists, and medical students . Anesth Analg . 1992;75:118-124.Article
8.
Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR.  Immunization policies and vaccine coverage among adults: the risk for missed opportunities . Ann Intern Med . 1988;108:616-622.Article
9.
Welch J, Webster M, Tilzey AJ, et al.  Hepatitis B infections after gynaecologic surgery . Lancet . 1989;1:205-207.Article
10.
Howard RJ.  Human immunodeficiency virus, hepatitis, and the surgeon . Perspect Gen Surg . 1992;3:37-53.
11.
Manian FA.  Hepatitis vaccination among physicians: a decade later . Infect Control Hosp Epidemiol . 1991;12:576.Article
12.
Lettau LA, Blackhurst DW, Steed C.  Human immunodeficiency virus testing experience and hepatitis B vaccination status of healthcare workers in South Carolina: implications for compliance with US Public Health Service guidelines . Infect Control Hosp Epidemiol . 1992;13:336-342.Article
13.
Harris AA, Daly-Gwenada D, Hudson EK.  Vaccine choice and program participation rates when two hepatitis B vaccines are offered . J Occup Med . 1991; 33:804-807.Article
14.
Alexander PG, Johnson R, Williams WW, Hadler SC, White JW, Coleman PJ.  Hepatitis B vaccination programs for health care personnel in US hospitals . Public Health Rep . 1990;105:610-616.
15.
Berridge BC. Galea MH, Evans DF, Pugh S, Hopkinson BR, Makin GS.  Hepatitis B immunization in vascular surgeons . Br J Surg . 1990;77:585-586.Article
16.
Williams JR, Flowerdew AD.  Uptake of immunisation against hepatitis B among surgeons in Wessex Regional Health Authority . BMJ . 1990:301:154.Article
17.
Panlilio AL, Foy DR, Edwards JR, et al.  Blood contacts during surgical procedures . JAMA . 1991;265:1533-1537.Article
18.
Gerberding JL, Littell C, Tarkington A, Brown A, Schecter WP.  Risk of exposure of surgical personnel to patient's blood during surgery at San Francisco General Hospital . N Engl J Med . 1990;322:1788-1793.Article
19.
Centers for Disease Control.  Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposureprone invasive procedures . MMWR Morb Mortal Wkly Rep . 1991;40( (suppl RR-8) ):1-9.
20.
Alper CA, Kruskall MS, Marcus-Bagley D, et al.  Genetic prediction of nonresponse to hepatitis B vaccine . N Engl J Med . 1989;321:708-712.Article
21.
Rogan PD, Diugid JR.  Immunisation of staff of a regional blood transfusion centre with a recombinant hepatitis B vaccine . J Infect (London) . 1991;22:5-9.Article
22.
Wainright RB, McMahon BJ, Bulkow LR.  Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population . JAMA . 1989;261: 2362-2366.Article
23.
McMahon BJ, Helminiak BJ, Wainright RB, Bulkow L, Trimble BA, Wainright K.  Frequence of adverse reactions to hepatitis B vaccine in 43 610 persons . Am J Med . 1992;92:254-256.Article
24.
Egea E, Iglesias A, Salazar M, et al.  The cellular basis for lack of antibody response to hepatitis B vaccine in humans . J Exp Med . 1991;173:531-538.Article
25.
Morris CA, Oliver PA, Reynolds F, et al.  Intradermal hepatitis B immunization with yeast-derived vaccine: serologic responses by sex and age . Epidemiol Infect . 1989;103:407-409.
26.
Struve J, Aronnson B, Frenning B, Granath F, von Sidow M, Weiland O.  Intramuscular versus intradermal administration of a recombinant hepatitis B vaccine: a comparison of response rates and analysis of factors influencing the antibody response . Scand J Infect Dis . 1992;24:423-429.Article
27.
Rivey MP, Peterson J.  Intradermal hepatitis B vaccination . Drug Intell Clin Pharmacol (US) . 1991;25:628-634.
28.
Centers for Disease Control.  Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B: United States, 1990-1991 . MMWR Morb Mortal Wkly Rep . 1991;40:569-572.
29.
Burden AD, Whorwell PJ.  Poor uptake of hepatitis B immunization amongst hospital-based health care staff . Postgrad Med J . 1991;67:256-258.Article
30.
Wainwright RB. McMahon BJ, Bulko LR, et al.  Protection provided by hepatitis B vaccine in a Yupik Eskimo population . Arch Intern Med . 1991;151:1634-1636.Article
31.
Davis JM, Demling RH, Lewis FR, Hoover E, Waymack JP.  The Surgical Infection Society's policy on human immunodeficiency virus and hepatitis B and C infection: the Ad Hoc Committee on Acquired Immunodeficiency Syndrome and Hepatitis . Arch Surg . 1992;127:218-221.Article
32.
Bush LM, Moonsamny GI, Boscia JA.  Evaluation of initiating a hepatitis B vaccination schedule with one vaccine and completing it with another . Vaccine . 1991;9:23-27.Article
×